These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trichloroacetic acid: updated estimates of its bioavailability and its contribution to trichloroethylene-induced mouse hepatomegaly. Chiu WA Toxicology; 2011 Jul; 285(3):114-25. PubMed ID: 21549800 [TBL] [Abstract][Full Text] [Related]
3. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice. Bull RJ; Sasser LB; Lei XC Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791 [TBL] [Abstract][Full Text] [Related]
4. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly. Evans MV; Chiu WA; Okino MS; Caldwell JC Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323 [TBL] [Abstract][Full Text] [Related]
5. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594 [TBL] [Abstract][Full Text] [Related]
6. Impact of repeated exposure on toxicity of perchloroethylene in Swiss Webster mice. Philip BK; Mumtaz MM; Latendresse JR; Mehendale HM Toxicology; 2007 Mar; 232(1-2):1-14. PubMed ID: 17267091 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans. Chiu WA; Ginsberg GL Toxicol Appl Pharmacol; 2011 Jun; 253(3):203-34. PubMed ID: 21466818 [TBL] [Abstract][Full Text] [Related]
8. Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. Völkel W; Friedewald M; Lederer E; Pähler A; Parker J; Dekant W Toxicol Appl Pharmacol; 1998 Nov; 153(1):20-7. PubMed ID: 9875296 [TBL] [Abstract][Full Text] [Related]
9. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Templin MV; Parker JC; Bull RJ Toxicol Appl Pharmacol; 1993 Nov; 123(1):1-8. PubMed ID: 8236248 [TBL] [Abstract][Full Text] [Related]
10. Bayesian analysis of a physiologically based pharmacokinetic model for perchloroethylene in humans. Qiu J; Chien YC; Bruckner JV; Fisher JW J Toxicol Environ Health A; 2010; 73(1):74-91. PubMed ID: 19953421 [TBL] [Abstract][Full Text] [Related]
11. Effect of dichloroacetic acid and trichloroacetic acid on DNA methylation in liver and tumors of female B6C3F1 mice. Tao L; Kramer PM; Ge R; Pereira MA Toxicol Sci; 1998 Jun; 43(2):139-44. PubMed ID: 9710955 [TBL] [Abstract][Full Text] [Related]
12. The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. DeAngelo AB; Daniel FB; Wong DM; George MH J Toxicol Environ Health A; 2008; 71(16):1056-68. PubMed ID: 18569617 [TBL] [Abstract][Full Text] [Related]
13. Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice. Dalaijamts C; Cichocki JA; Luo YS; Rusyn I; Chiu WA Toxicol Appl Pharmacol; 2018 Aug; 352():142-152. PubMed ID: 29857080 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans. Reitz RH; Gargas ML; Mendrala AL; Schumann AM Toxicol Appl Pharmacol; 1996 Feb; 136(2):289-306. PubMed ID: 8619237 [TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. Greenberg MS; Burton GA; Fisher JW Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286 [TBL] [Abstract][Full Text] [Related]
16. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Abbas R; Fisher JW Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303 [TBL] [Abstract][Full Text] [Related]
17. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Stauber AJ; Bull RJ; Thrall BD Toxicol Appl Pharmacol; 1998 Jun; 150(2):287-94. PubMed ID: 9653059 [TBL] [Abstract][Full Text] [Related]
19. Failure of monochloroacetic acid and trichloroacetic acid administered in the drinking water to produce liver cancer in male F344/N rats. DeAngelo AB; Daniel FB; Most BM; Olson GR J Toxicol Environ Health; 1997 Dec; 52(5):425-45. PubMed ID: 9388534 [TBL] [Abstract][Full Text] [Related]
20. Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Tao L; Li Y; Kramer PM; Wang W; Pereira MA Toxicology; 2004 Mar; 196(1-2):127-36. PubMed ID: 15036762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]